Certified by Founder
Lodge
Sift Biosciences
start up
United States
- San Carlos, CA
- 19/02/2026
- Pre-Seed
- $3,700,000
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
- Industry Biotechnology Research
- Website https://siftbio.com/
- LinkedIn https://www.linkedin.com/company/sift-biosciences/
Related People
Yue Clare Lou, Ph.D.Co Founder
United States -
San Francisco Bay Area
Scientist | Founder
Immunology | Cancer <> AI/Bioinformatics <> Microbiology
EnerVenue | $300,000,000 | (Apr 3, 2026)
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
daydream | $15,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Alien | $7,100,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)